Company Filing History:
Years Active: 2022-2025
Title: Innovations by Inventor Kimberly Hassett
Introduction
Kimberly Hassett, an accomplished inventor based in Cambridge, MA, has made significant contributions to the field of biotechnology. With a focus on lipid nanoparticles and mRNA vaccines, she holds two patents that showcase her innovative spirit and dedication to advancing medical science.
Latest Patents
Her latest patents reflect cutting-edge research aimed at improving therapeutic delivery systems. The first patent is titled "Methods of Making Lipid Nanoparticles," which features novel techniques for producing nucleic acid lipid nanoparticle (LNP) compositions. This innovation involves employing a modifying agent post-formation of precursor LNPs. The resulting compositions are pivotal in delivering therapeutics or prophylactics, including nucleic acids, to mammalian cells to regulate polypeptide, protein, or gene expression.
The second patent, related to a "Human Cytomegalovirus Vaccine," addresses methods for eliciting an antigen-specific immune response against human cytomegalovirus (hCMV) by administering mRNA vaccines. This work stands to enhance vaccination strategies and improve patient outcomes against viral infections.
Career Highlights
Currently, Kimberly is a key contributor at ModernaTx, Inc., where she applies her expertise to pioneer advancements in vaccine technology and therapeutic delivery. Under her guidance, the company has made remarkable strides in mRNA technology.
Collaborations
Throughout her career, Kimberly has collaborated with several notable colleagues, including Jack F. Kramarczyk and Shinu John. These partnerships have been instrumental in developing innovative solutions that address pressing health challenges.
Conclusion
Kimberly Hassett is a notable inventor whose work in lipid nanoparticles and mRNA vaccines has the potential to transform the landscape of medical therapeutics. With her impressive patent portfolio, she continues to drive innovation within the biotechnology sector, paving the way for new therapeutic strategies and improved patient care.